nach oben

Erschienen in:

21.12.2020 | Peeling | Leitlinien, Stellungnahmen und Empfehlungen

Stellungnahme von BVA, DOG und RG zur Entwicklung, Diagnostik und Behandlung der epiretinalen Gliose

Stand Oktober 2020

verfasst von: Berufsverband der Augenärzte Deutschlands e. V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e. V. (RG)

Erschienen in: Die Ophthalmologie | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Auszug

Neben der idiopathischen Form, bei der altersbedingte Glaskörperveränderungen primär an der Pathogenese beteiligt sind, treten epiretinale Membranen auch sekundär bei anderen Erkrankungen von Retina und Glaskörper auf, z. B. bei:

diabetischem Makulaödem,
retinalem Venenverschluss,
peripherem Netzhautforamen oder Ablatio retinae,
Zustand nach Kryo- oder Lasertherapie der Netzhaut,
vaskulären, entzündlichen und traumabedingten Netzhauterkrankungen.

…

Nur mit Berechtigung zugänglich

Agrawal A (2012) Macular dysfunction caused by epiretinal membrane contraction. In: Gass’ Atlas of macular diseases, 5. Aufl. Bd. 1. Elsevier, Amsterdam, S 672

Ahn SJ, Ahn J, Woo SJ et al (2014) Photoreceptor change and visual outcome after idiopathic epiretinal membrane removal with or without additional internal limiting membrane peeling. Retina 34:172–181PubMedCrossRef

Akiyama K, Fujinami K, Watanabe K et al (2016) Internal limiting membrane peeling to prevent post-vitrectomy epiretinal membrane development in retinal detachment. Am J Ophthalmol 171:1–10PubMedCrossRef

Ando F, Sasano K, Ohba N et al (2004) Anatomic and visual outcomes after indocyanine green-assisted peeling of the retinal internal limiting membrane in idiopathic macular hole surgery. Am J Ophthalmol 137:609–614PubMed

Asaria R, Garnham L, Gregor ZJ, Sloper JJ (2008) A prospective study of binocular visual function before and after successful surgery to remove a unilateral epiretinal membrane. Ophthalmology 115(11):1930–1937. https://doi.org/10.1016/j.ophtha.2008.05.020CrossRefPubMed

Azuma K, Ueta T, Eguchi S et al (2017) Effects of internal limiting membrane peeling combined with removal of idiopathic epiretinal membrane: a systematic review of literature and meta-analysis. Retina 37(10):1813–1819. https://doi.org/10.1097/IAE.0000000000001537CrossRefPubMed

Bartz-Schmidt K‑U, Bertram B, Bornfeld N et al (2013) Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013). Klin Monbl Augenheilkd 230:629–634PubMedCrossRef

Bellocq D, Korobelnik JF, Burillon C et al (2015) Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol 99:979–983PubMedCrossRef

Beutel J, Dahmen G, Ziegler A, Hoerauf H (2007) Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 125(3):326–332PubMedCrossRef

10.

Blodi BA, Paluska SA (1997) Cataract after vitrectomy in young patients. Ophthalmology 104:1092–1095. https://doi.org/10.1016/s0161-6420(97)30180-8CrossRefPubMed

11.

Bottoni F (2019) Fundus autofluorescence in lamellar macular holes and pseudoholes: a review. J Ophthalmol 10:4948212. https://doi.org/10.1155/2019/4948212CrossRef

12.

Bovey EH, Uffer S, Achache F (2004) Surgery for epimacular membrane: impact of retinal internal limiting membrane removal on functional outcome. Retina 24:728–735PubMedCrossRef

13.

de Bustros S, Rice TA, Michels RG et al (1988a) Vitrectomy for macular pucker. Use after treatment of retinal tears or retinal detachment. Arch Ophthalmol 106:758–760. https://doi.org/10.1001/archopht.1988.01060130828032CrossRefPubMed

14.

de Bustros S, Thompson JT, Michels RG et al (1988b) Vitrectomy for idiopathic epiretinal membranes causing macular pucker. Br J Ophthalmol 72(9):692–695. https://doi.org/10.1136/bjo.72.9.692CrossRefPubMedPubMedCentral

15.

de Bustros S, Thompson JT, Michels RG et al (1988c) Nuclear sclerosis after vitrectomy for idiopathic epiretinal membranes. Am J Ophthalmol 105:160–164. https://doi.org/10.1016/0002-9394(88)90180-8CrossRefPubMed

16.

Christodoulou E, Bastos G, Galinis P et al (2020) Vitrectomy for the removal of idiopathc epiretinal membrane with or without internal limitingmembrane peeling:a meta-analysis. Ophthalmol Eye Dis 12:1–11CrossRef

17.

Cohen SM, Flynn HW, Murray TG, Smiddy WE (1995) Endophthalmitis after pars plana vitrectomy. The Postvitrectomy Endophthalmitis Study Group. Ophthalmology 102(5):705–712PubMedCrossRef

18.

Cox MS, Azen SP, Barr CC et al (1995) Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study Report 8. Ophthalmology 102:1884–1891. https://doi.org/10.1016/s0161-6420(95)30779-8CrossRefPubMed

19.

Dawson SR, Shunmugam M, Williamson TH (2014) Visual acuity outcomes following surgery for idiopathic epiretinal membrane: an analysis of data from 2001 to 2011. Eye 28(2):219–224. https://doi.org/10.1038/eye.2013.253CrossRefPubMed

20.

Duan XR, Liang YB, Friedman DS et al (2009) Prevalence and associations of epiretinal membranes in a rural Chinese adult population: the Handan Eye Study. Invest Ophthalmol Vis Sci 50:2018–2023PubMedCrossRef

21.

Ducloyer JB, Ivan J, Poinas A et al (2020) Does internal limiting membrane peeling during epiretinal membrane surgery induce microscotomas on microperimetry? Study protocol for PEELING, a randomized controlled clinical trial. Trials 21(1):500. https://doi.org/10.1186/s13063-020-04433-9CrossRefPubMedPubMedCentral

22.

Díaz-Valverde A, Wu L (2018) To peel or not to peel the internal limiting membrane in idiopathic epiretinal membranes. Retina 38(Suppl 1):S5–S11. https://doi.org/10.1097/IAE.0000000000001906CrossRefPubMed

23.

Falkner-Radler CI, Glittenberg C, Hagen S et al (2010) Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology 117(4):798–805. https://doi.org/10.1016/j.ophtha.2009.08.034CrossRefPubMed

24.

Farah ME, Maia M, Furlani B et al (2008) Current concepts of trypan blue in chromovitrectomy. Dev Ophthalmol 42:91–100PubMedCrossRef

25.

Feng HL, Sharma S, Stinnett S et al (2019) Identification of posterior segment pathology with en face retinal imaging using multicolour confocal scanning laser ophthalmoscopy. Retina 39:972–979PubMedCrossRef

26.

Forlini M, Date P, Ferrari LM et al (2018) Comparative analysis of retinal reattachment surgery with or without internal limiting membrane peeling to prevent postoperative macular pucker. Retina 38(9):1770–1776. https://doi.org/10.1097/IAE.0000000000001775CrossRefPubMed

27.

Foveau P, Leroy B, Berrod JP, al ez (2018) Internal limiting membrane peeling in macula-off retinal detachment complicated by grade B proliferative vitreoretinopathy. Am J Ophthalmol 191:1–6. https://doi.org/10.1016/j.ajo.2018.03.037CrossRefPubMed

28.

Frisina R, Pinackatt SJ, Sartore M et al (2015) Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch Clin Exp Ophthalmol 253(1):47–56. https://doi.org/10.1007/s00417-014-2655-xCrossRefPubMed

29.

Furashova O, Engelmann K (2020) To peel or not to peel: pars plana vitrectomy with macular membrane peel in eyes with abnormalities of vitreomacular interface and coexisting dry Age-related macular degeneration. Clin Ophthalmol 14:389–396. https://doi.org/10.2147/OPTH.S240480CrossRefPubMedPubMedCentral

30.

Furino C, Boscia F, Recchimurzo N, Sborgia C, Alessio G (2014) Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker. Retina 34(8):1612–1616PubMedCrossRef

31.

Gaber R, You QS, Muftuoglu IK et al (2017) Characteristics of epiretinal membrane remnant edge by optical coherence tomography after pars plana vitrectomy. Retina 37(11):2078–2083. https://doi.org/10.1097/IAE.0000000000001466CrossRefPubMedPubMedCentral

32.

Gandorfer A, Scheler R, Schumann R et al (2009) Interference microscopy delineates cellular proliferation on flat mounted internal limiting membrane specimens. Br J Ophthalmol 93:120–122PubMedCrossRef

33.

Gandorfer A, Haritoglou C, Scheler R et al (2012) Residual cellular proliferation on the internal limiting membrane in macular pucker surgery. Retina 32:477–485PubMedCrossRef

34.

Gandorfer A, Haritoglou C, Kampik A (2008) Toxicity of indocyanine green in vitreoretinal surgery. Dev Ophthalmol 42:69–81. https://doi.org/10.1159/000138974CrossRefPubMed

35.

Gandorfer A, Rohleder M, Kampik A (2002) Epiretinal pathology of vitreomacular traction syndrome. Br J Ophthalmol 86:902–909PubMedPubMedCentralCrossRef

36.

Gandorfer A, Schumann R, Scheler R, Haritoglou C, Kampik A (2011) Pores of the inner limiting membrane in flat-mounted surgical specimens. Retina 31(5):977–981PubMedCrossRef

37.

Ghezala BI, Mariet AS, Benzenine E et al (2020) Incidence of acute postoperative endophthalmitis following macular surgery in France between 2006 and 2016. Acta Ophthalmol 98(3):e333–e338. https://doi.org/10.1111/aos.14279CrossRefPubMed

38.

Govetto A, Virgili G, Rodriguez FJ et al (2019) Functional and anatomical significance of the ectopic inner foveal layers in eyes with idiopathic epiretinal membranes: Surgical results at 12 months. Retina 39(2):347–357. https://doi.org/10.1097/IAE.0000000000001940CrossRefPubMed

39.

Grewing R, Mester U (1996) Results of surgery for epiretinal membranes and their recurrences. Br J Ophthalmol 80(4):323–326. https://doi.org/10.1136/bjo.80.4.323CrossRefPubMedPubMedCentral

40.

Guber J, Pereni I, Scholl HPN et al (2019) Outcomes after epiretinal membrane surgery with or without internal limiting membrane peeling. Ophthalmol Ther 8(2):297–303. https://doi.org/10.1007/s40123-019-0185-7CrossRefPubMedPubMedCentral

41.

Guenther SR, Schumann RG, Hagenau F et al (2019) Comparison of surgically excised premacular membranes in eyes with macular pucker and proliferative vitreoretinopathy. Curr Eye Res 44:341–349PubMedCrossRef

42.

Hahn U, Krummenauer F, Ludwig L (2018) 23G pars plana vitrectomy for vitreal floaters: prospective assessment of subjective self-reported visual impairment and surgery-related risks during the course of treatment. Graefes Arch Clin Exp Ophthalmol. https://doi.org/10.1007/s00417-018-3979-8CrossRefPubMed

43.

Haritoglou C, Gandorfer A, Gass CA et al (2002) Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 134:836–841PubMedCrossRef

44.

Haritoglou C, Gandorfer A, Gass CA et al (2003) The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 135:328–337PubMedCrossRef

45.

Haritoglou C, Schumann R, Reiniger I, Rohleder M, Priglinger SG, Kampik A, Gandorfer A (2006) Evaluation of the internal limiting membrane after conventional peeling during macular hole surgery. Retina 26:21–24PubMedCrossRef

46.

Haritoglou C, Schumann RG, Kampik A, Gandorfer A (2007) Glial cell proliferation under the internal limiting membrane in a patient with cellophane maculopathy. Arch Ophthalmol 125:1301–1302PubMedCrossRef

47.

Haritoglou C, Schumann RG, Wolf A (2014) Epiretinal gliosis. Ophthalmologe 111:485–497. https://doi.org/10.1007/s00347-014-3040-1 (German)CrossRefPubMed

48.

Hattenbach LO (2020) The role of Intraoperative microscope-integrated OCT in retinal surgery. Part 1: pro. Klin Monbl Augenheilkd. https://doi.org/10.1055/a-1193-9045CrossRefPubMed

49.

Hattenbach LO, Kuhli-Hattenbach C, Springer C et al (2016) Intravitreal dexamethasone implant for treatment of persistent postoperative macular edema after vitrectomy. Ophthalmologe 113(7):581–588. https://doi.org/10.1007/s00347-016-0223-yCrossRefPubMed

50.

Hattenbach LO, Springer-Wanner C, Hoerauf H et al (2017) Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of Epiretinal membranes. Ophthalmologica 237(4):232–237. https://doi.org/10.1159/000464259CrossRefPubMed

51.

Heegaard S (1997) Morphology of the vitreoretinal border region. Acta Ophthalmol Scand Suppl 222:1–31

52.

Hillenkamp J, Saikia P, Gora F et al (2005) Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol 89(4):437–443. https://doi.org/10.1136/bjo.2004.051250CrossRefPubMedPubMedCentral

53.

Hillenkamp J, Saikia P, Herrmann WA et al (2007) Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 245(7):973–979. https://doi.org/10.1007/s00417-006-0485-1CrossRefPubMed

54.

Hisatomi T, Notomi S, Tachibana T et al (2015) Brilliant Blue G double staining enhances successful internal limiting membrane peeling with minimal adverse effect by low cellular permeability into live cells. Retina 35(2):310–318. https://doi.org/10.1097/IAE.0000000000000289CrossRefPubMed

55.

Hiscott PS, Grierson I, Trombetta CJ et al (1984) Retinal and epiretinal glia—an immunochistochemical study. Br J Ophthalmol 68:698–707PubMedPubMedCentralCrossRef

56.

Hubschman JP, Govetto A, Spaide RF et al (2020) Optical coherence tomography-based consensus definition for lamellar macular hole. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2019-315432CrossRefPubMed

57.

Inoue M, Kadonosono K (2014) Macular diseases: epiretinal membranes. Dev Ophthalmol 54:159–163PubMedCrossRef

58.

Ishida Y, Iwama Y, Nakashima H et al (2020) Risk factors, onset, and progression of epiretinal membrane after 25-gauge pars plana vitrectomy for rhegmatogenous retinal detachment. Ophthalmol Retin 4(3):284–288CrossRef

59.

Iwanoff A (1865) Beiträge zur normalen und pathologischen Anatomie des Auges. Arch Ophthalmol 11:135–170

60.

Johnson MW (2009) Etiology and treatment of macular edema. Am J Ophthalmol 147(1):11–21e1PubMedCrossRef

61.

Johnson MW (2010) Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol 49:371–382CrossRef

62.

Kampik A, Green WR, Michels RG et al (1980) Ultrastructural features of progressive idiopathic epiretinal membrane removed by vitreous surgery. Am J Ophthalmol 90:797–809PubMedCrossRef

63.

Kampik A, Kenyon KB, Michels RG et al (1981) Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol 99:1445–1454PubMedCrossRef

64.

Kim JH, Kang SW, Kong MG, Ha HS (2013) Assessment of retinal layers and visual rehabilitation after epiretinal membrane removal. Graefes Arch Clin Exp Ophthalmol 251(4):1055–1064. https://doi.org/10.1007/s00417-012-2120-7CrossRefPubMed

65.

Kim SJ, Martin DF, Hubbard GB 3rd et al (2009) Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology 116(8):1531–1537PubMedCrossRef

66.

Kim YJ, Lee KS, Joe SG, Kim JG (2018) Incidence and quantitative analysis of dissociated optic nerve fiber layer appearance: real loss of retinal nerve fiber layer? Eur J Ophthalmol 28(3):317–323. https://doi.org/10.5301/ejo.5001067CrossRefPubMed

67.

Kinoshita T, Imaizumi H, Okushiba U et al (2012) Time course of changes in metamorphopsia, visual acuity, and OCT parameters after successful epiretinal membrane surgery. Invest Ophthalmol Vis Sci 53(7):3592–3597. https://doi.org/10.1167/iovs.12-9493CrossRefPubMed

68.

Kinoshita T, Imaizumi H, Miyamoto H et al (2016) Two-year results of metamorphopsia, visual acuity, and optical coherence tomographic parameters after epiretinal membrane surgery. Graefes Arch Clin Exp Ophthalmol 254(6):1041–1049. https://doi.org/10.1007/s00417-015-3147-3CrossRefPubMed

69.

Klein R, Klein BE, Wang Q, Moss SE (1994) The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc 92:403–425 (discussion 425–30)PubMedPubMedCentral

70.

Konstantinidis L, Berguiga M, Beknazar E, Wolfensberger TJ (2009) Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane. Retina 29(8):1119–1127PubMedCrossRef

71.

Konstantopoulos A, Williams CP, Luff AJ (2008) Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema. Eye 22(2):219–222PubMedCrossRef

72.

Kumagai K, Furukawa M, Suetsugu T, Ogino N (2018) Foveal avascular zone area after internal limiting membrane peeling for epiretinal membrane and macular hole compared aith that of fellow eyes and healthy controls. Retina 38(9):1786–1794. https://doi.org/10.1097/IAE.0000000000001778CrossRefPubMed

73.

Kumar K, Chandnani N, Raj P et al (2016) Clinical outcomes of double membrane peeling with or without simultaneous phacoemulsification/gas tamponade for vitreoretinal-interface-associated (VRI) disorders. Int Ophthalmol 36:547–556PubMedCrossRef

74.

Kwok AK, Lai TY, Man-Chan W et al (2003) Indocyanine green assisted retinal internal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol 87:71–74PubMedPubMedCentralCrossRef

75.

Kwok AK, Lai TY, Li WW et al (2004) Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study. Am J Ophthalmol 138(2):194–199. https://doi.org/10.1016/j.ajo.2004.03.013CrossRefPubMed

76.

Lee SM, Pak KY, Know HJ et al (2018) Association between tangetial contraction and early vision loss in idiopathic eprretinal mambrane. Retina. https://doi.org/10.1097/IAE.00000000001559CrossRefPubMedPubMedCentral

77.

Leisser C, Hirnschall N, Palkovits S et al (2019) Intraoperative optical coherence tomography-guided membrane peeling for surgery of macular pucker: advantages and limitations. Ophthalmologica 241(4):234–240. https://doi.org/10.1159/000493279CrossRefPubMed

78.

Leisser C, Palkovits S, Hienert J et al (2020) Effect of iatrogenic traction during macular peeling surgery on postoperative microperimetry. Ophthalmic Res. https://doi.org/10.1159/000507633CrossRefPubMed

79.

Liesenborghs I, De Clerck EEB, Berendschot TTJM et al (2018) Prevalence of optical coherence tomography detected vireomacular interface disorders: the Maastricht Study. Acta Ophthalmol 96:729–736PubMedPubMedCentralCrossRef

80.

Liu H, Zuo S, Ding C et al (2015) Comparison of the effectiveness of pars plana vitrectomy with and without internal limiting membrane peeling for idiopathic retinal membrane removal: a meta-analysis. J Ophthalmol 97:45–68. https://doi.org/10.1155/2015/974568CrossRef

81.

Lommatzsch A, Heimes B, Trieschmann M et al (2008) Long-term results after pars plana vitrectomy with 25 gauge technique. Ophthalmologe 105(5):445–451PubMedCrossRef

82.

Machado LM, Furlani BA, Navarro RM et al (2015) Preoperative and intraoperative prognostic factors of epiretinal membranes using chromovitrectomy and internal limiting membrane peeling. Ophthalmic Surg Lasers Imaging Retina 46:457–462PubMedCrossRef

83.

Maier M, Hattenbach LO, Klein J et al (2020) Real-time optical coherence tomography-assisted high-precision vitreoretinal surgery in the clinical routine. Ophthalmologe 117(2):158–165. https://doi.org/10.1007/s00347-019-01007-2CrossRefPubMed

84.

Margherio RR, Cox MS, Trese MT et al (1985) Removal of epimacular membranes. Ophthalmology 92(8):1075–1083PubMedCrossRef

85.

Martins D, Neves P (2018) Epiretinal membrane negative staining and double peeling in a single block with Brilliant Blue G. Eur J Ophthalmol 28(1):112–116. https://doi.org/10.5301/ejo.5000975CrossRefPubMed

86.

Da Mata AP, Burk SE, Riemann CD et al (2001) Indocyanine-green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 108:1187–1192PubMedCrossRef

87.

Meuer SM, Myers CE, Klein BE et al (2015) The epidemiology of vitreoretinal interface abnormalities as detected by spectral-domain optical coherence tomography: the beaver dam eye study. Ophthalmology 122:787–795PubMedCrossRef

88.

Miguel AI, Legris A (2017) Prognostic factors of epiretinal membranes: a systematic review. J Fr Ophtalmol 40(1):61–79. https://doi.org/10.1016/j.jfo.2016.12.001CrossRefPubMed

89.

Mitamura Y, Ohtsuka K (2005) Relationship of dissociated optic nerve fiber layer appearance to internal limiting membrane peeling. Ophthalmology 112(10):1766–1770. https://doi.org/10.1016/j.ophtha.2005.04.026CrossRefPubMed

90.

Mitchell P, Smith W, Chey T, Wang JJ, Chang A (1997) Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology 104:1033–1040PubMedCrossRef

91.

Momota A, Iwase T, Akahori T et al (2020) Association between displacement and thickness of macula after vitrectomy in eyes with epiretinal membrane. Sci Rep 10(1):13227. https://doi.org/10.1038/s41598-020-70197-6CrossRefPubMedPubMedCentral

92.

Muftuoglu IK, Amador M, Meshi A et al (2019) Foveal avascular zone distorsion in epiretinal membrane by optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina 50:295–301PubMedCrossRef

93.

Nelis P, Alten F, Clemens CR et al (2017) Quantification of changes in foveal capillary architecture caused by idiopathic epiretinal membrane using OCT angiography. Graefes Arch Clin Exp Ophthalmol 255:1319–1324PubMedCrossRef

94.

Ng Ch, Cheung N, Wang JJ et al (2011) Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology 118:694–699PubMedCrossRef

95.

Nitta E, Shiraga F, Shiragami C et al (2013) Displacement of the retina and its recovery after vitrectomy in idiopathic epiretinal membrane. Am J Ophthalmol 155(6):1014–1020.e1. https://doi.org/10.1016/j.ajo.2013.01.021CrossRefPubMed

96.

Niwa T, Terasaki H, Kondo M et al (2003) Function and morphology of macula before and after removal of idiopathic epiretinal membrane. Invest Ophthalmol Vis Sci 44:1652–1656PubMedCrossRef

97.

De Novelli FJ, Goldbaum M, Monteiro MLR et al (2019) Surgical removal of epiretinal membrane with and without removal of internal limiting membrane: comparative study of visual acuity, features of optical coherence tomography, and recurrence rate. Retina 39:601–607PubMedCrossRef

98.

Oh HN, Lee JE, Kim KW (2013) Clinical outcomes of double staining and additional ILM peeling during ERM surgery. Korean J Ophthalmol 27(4):256–260PubMedPubMedCentralCrossRef

99.

Ohji M, Tano Y (1995) Membrane delaminating wedge. Arch Ophthalmol 113(10):1335–1336. https://doi.org/10.1001/archopht.1995.01100100123044CrossRefPubMed

100.

Oster SF, Mojana F, Brar M et al (2010) Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence tomography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina 30(5):713–718PubMedCrossRef

101.

Otsuka H, Kawano H, Sonoda S, Nakamura M, Sakamoto T (2013) Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Invest Ophthalmol Vis Sci 54(3):1758–1766PubMedCrossRef

102.

Pang CE, Spaide RF, Freund KB (2014) Epiretinal proliferation seen in association with lamellar macular holes: a distinct clinical entity. Retina 34:1513–1523PubMedCrossRef

103.

Parolini B, Schumann RG, Cereda MG, Haritoglou C, Pertile G (2011) Lamellar macular hole: a clinicopathologic correlation of surgically excised epiretinal membranes. Invest Ophthalmol Vis Sci 52:9074–9083PubMedCrossRef

104.

Peyman GA (1989) A combination pick and flute needle. Arch Ophthalmol 107(11):1687. https://doi.org/10.1001/archopht.1989.01070020765045CrossRefPubMed

105.

Pierro L, Iuliano L, Gagliardi M et al (2015) Role of ganglion cell complex in visual recovery following surgical internal limiting membrane peeling. Graefes Arch Clin Exp Ophthalmol 253(1):37–45. https://doi.org/10.1007/s00417-014-2665-8CrossRefPubMed

106.

Pournaras CJ, Emarah A, Petropoulos IK (2011) Idiopathic macular epiretinal membrane surgery and ILM peeling: anatomical and functional outcomes. Semin Ophthalmol 26:42–46PubMedCrossRef

107.

Rice TA, De Bustros S, Michels RG et al (1986) Prognostic factors in vitrectomy for epiretinal membranes of the macula. Ophthalmology 93:602–610. https://doi.org/10.1016/s0161-6420(86)33689-3CrossRefPubMed

108.

Rodrigues EB, Meyer CH, Kroll P (2005) Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 243(4):291–293PubMedCrossRef

109.

Romano MR, Ilardi G, Ferrara M et al (2018) Macular peeling-induced retinal damage: clinical and histopathological evaluation after using different dyes. Graefes Arch Clin Exp Ophthalmol 256(9):1573–1580. https://doi.org/10.1007/s00417-018-4029-2CrossRefPubMed

110.

Russo A, Morescalchi F, Gambicorti E et al (2019) Epiretinal membrane removal with foveal-sparing internal limiting membrane peeling: a Pilot Study. Retina 39(11):2116–2124. https://doi.org/10.1097/IAE.0000000000002274CrossRefPubMed

111.

Schechet SA, DeVience E, Thompson JT (2017) The effect of internal limiting membrane peeling on idiopathic epiretinal membrane surgery, with a review of the literature. Retina 37(5):873–880. https://doi.org/10.1097/IAE.0000000000001263CrossRefPubMed

112.

Schmid-Kubista KE, Lamar PD, Schenk A et al (2010) Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 248(3):381–388. https://doi.org/10.1007/s00417-009-1213-4CrossRefPubMed

113.

Schulz. Hey S, Carlsson JO, Grafoord S (2011) Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. Acta Ophthalmol 89:159–165CrossRef

114.

Schumann RG, Gandorfer A (2014) Pathophysiology of vitreo-macular interface. In: Girach A, de Smet M (Hrsg) Diseases of the vitreo-macular interface. Singh AD. Springer, Heidelberg, S 43–53CrossRef

115.

Schumann RG, Gandorfer A, Eibl KH et al (2010) Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blue G‑assisted macular surgery. Br J Ophthalmol 94(10):1369–1372. https://doi.org/10.1136/bjo.2010.183210CrossRefPubMed

116.

Schumann RG, Gandorfer A, Ziada J et al (2014) Hyalocytes in idiopathic epiretinal membranes: a correlative light and electron microscopic study. Graefes Arch Clin Exp Ophthalmol 252:1887–1894PubMedCrossRef

117.

Schumann RG, Langer J, Compera D et al (2017) Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice. Graefes Arch Clin Exp Ophthalmol 255:2081–2089PubMedCrossRef

118.

Schumann RG, Hagenau F, Guenther SR et al (2019) Premacular cell proliferation profiles in tangential traction vitreo-maculopathies suggest a key role for hyalocytes. Ophthalmologica 242:106–101PubMedCrossRef

119.

Schuster AK, Kluck AK, Korb CA et al (2020) Characteristics and pathologies of the vitreo-macular interface—results from the Gutenberg health study. Acta Ophthalmol 98(3):e273–e281. https://doi.org/10.1111/aos.14285CrossRefPubMed

120.

Sebag J (2004) Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp 242:690–698CrossRef

121.

Sebag J (2008) Vitreochisis. Graefes Arch Clin Exp Ophthalmol 246:329–332PubMedPubMedCentralCrossRef

122.

Sebag J, Wang MY, Nguyen D et al (2009) Vitreopapillary adhesion in macular diseases. Trans Am Ophthalmol Soc 107:35–46PubMedPubMedCentral

123.

Sebag J, Gupta P, Rosen RR, Garcia P, Sadun AA (2007) Macular holes and macular pucker: the role of vitreoschisis as imaged by optical coherence tomography/scanning laser ophthalmoscopy. Trans Am Ophthalmol Soc 105:121–129PubMedPubMedCentral

124.

Shimada H, Nakashizuka H, Hattori T (2009) Double staining with brilliant blue G and double peeling for epiretinal membranes. Ophthalmology 116(7):1370–1376PubMedCrossRef

125.

Shiono A, Kogo J, Klose G et al (2013) Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membrane surgery. Ophthalmology 120(4):788–794. https://doi.org/10.1016/j.ophtha.2012.09.044CrossRefPubMed

126.

Snead DR, James S, Snead MP (2008) Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation. Eye 22:1310–1317. https://doi.org/10.1038/eye.2008.36CrossRefPubMed

127.

Stalmans P, Delaey C, De Smet MD et al (2010) Intravitreal injection of microplasmin for treatment of vitreomacular adhesion: results of a prospective, randomized, sham-controlled phase II trial (the MIVI-IIT trial). Retina 30:1122–1127PubMedCrossRef

128.

Stalmans P, Benz MS, Gandorfer A et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606–615PubMedCrossRef

129.

Staudt S, Miller DW, Unnebrink K, Holz FG (2003) Inzidenz und Ausprägung von postoperativem Makulaödem nach Makulaforamenoperation mit und ohne kombinierte Kataraktoperation. Ophthalmologe 100(9):702–707PubMedCrossRef

130.

Stefánsson E (2014) Vitreous physiology. In: Sebag J (Hrsg) Vitreous in health and disease. Springer, New York, S 437–457CrossRef

131.

Storch MW, Khattab MH, Lauermann P et al (2019) Macular pucker surgery with and without delamination of the internal limiting membrane—a prospective randomized study. Ophthalmologe 116(11):1038–1045. https://doi.org/10.1007/s00347-019-0936-9CrossRefPubMed

132.

Szurman P, Sierra A, Kaczmarek R et al (2002) Different biocompatibility of crystallinetriamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res 85(1):44–53CrossRef

133.

Takabatake M, Higashide T, Udagawa S, Sugiyama K (2018) Postoperative changes and prognostic factors of visual acuity, metamorphopsia, and aniseikonia after vitrectomy for epiretinal membrane. Retina 38(11):2118–2127. https://doi.org/10.1097/IAE.0000000000001831CrossRefPubMed

134.

Tranos P, Koukoula S, Charteris DG et al (2017) The role of internal limiting membrane peeling in epiretinal membrane surgery: a randomised controlled trial. Br J Ophthalmol 101:719–724PubMedCrossRef

135.

Trese MT, Chandler DB, Machemer R (1983) Macular pucker. I. Prognostic criteria. Graefes Arch Clin Exp Ophthalmol 221:12–15. https://doi.org/10.1007/BF02171725CrossRefPubMed

136.

Treumer F, Wacker N, Junge O et al (2011) Foveal structure and thickness of retinal layers long-term after surgical peeling of idiopathic epiretinal membrane. Invest Ophthalmol Vis Sci 52(2):744–750. https://doi.org/10.1167/iovs.10-6310CrossRefPubMed

137.

Uchida A, Srivastava SK, Ehlers JP (2017) Analysis of retinal architectural changes using Intraoperative OCT following surgical manipulations with membrane flex loop in the DISCOVER study. Invest Ophthalmol Vis Sci 58(9):3440–3444. https://doi.org/10.1167/iovs.17-21584CrossRefPubMedPubMedCentral

138.

Uchino E, Uemura A, Ohba N (2001) Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol 119:1475–1479PubMedCrossRef

139.

Uemura A, Kanda S, Sakamoto Y et al (2003) Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 136:252–257PubMedCrossRef

140.

Veritti D, Toneatto G, Lanzetta P (2012) Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery. Eur J Ophthalmol 22(4):626–634. https://doi.org/10.5301/ejo.5000066CrossRefPubMed

141.

Vote BJ, Russell MK, Joondeph BC (2004) Trypan blue-assisted vitrectomy. Retina 24(5):736–738. https://doi.org/10.1097/00006982-200410000-00008CrossRefPubMed

142.

Warrow DJ, Lai MM, Patel A et al (2015) Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin. Am J Ophthalmol 159:20–30PubMedCrossRef

143.

Weinberger AW, Schlossmacher B, Dahlke C et al (2002) Indocyanine-green-assisted internal limiting membrane peeling in macular hole surgery: a follow-up study. Graefes Arch Clin Exp Ophthalmol 240:913–917PubMedCrossRef

144.

Wise GN (1975) Clinical features of idiopathic preretinal macular fibrosis. Am J Ophthalmol 79:349PubMedCrossRef

145.

Wolf S, Reichel MB, Wiedemann P et al (2003) Clinical findings in macular hole surgery with indocyanine-green assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 241:589–592PubMedCrossRef

146.

Yannuzzi NA, Callaway NF, Sridhar J, Smiddy WE (2018) Internal limiting membrane peeling during pars plana vitrectomy for rhegmatogenous retinal detachment: cost analysis, review of the literature, and meta-analysis. Retina 38(10):2081–2087. https://doi.org/10.1097/IAE.0000000000002248CrossRefPubMed

147.

Zur D, Fischer N, Tufail A et al (2010) Postsurgical cystoid macular edema. Eur J Ophthalmol 21(S6):62–68

148.

Mayer WJ, Vogel M, Neubauer A et al (2013) Pars plana vitrectomy and internal limiting membrane peeling in epimacular membranes: correlation of function and morphology across the macula. Ophthalmologica 230:9–17PubMedCrossRef

Titel: Stellungnahme von BVA, DOG und RG zur Entwicklung, Diagnostik und Behandlung der epiretinalen Gliose
Stand Oktober 2020
verfasst von: Berufsverband der Augenärzte Deutschlands e. V. (BVA)
Deutsche Ophthalmologische Gesellschaft (DOG)
Retinologische Gesellschaft e. V. (RG)
Publikationsdatum: 21.12.2020
Verlag: Springer Medizin
Schlagwörter: Peeling
Vitrektomie
Erschienen in: Die Ophthalmologie / Ausgabe 2/2021
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-020-01291-3

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Stellungnahme von BVA, DOG und RG zur Entwicklung, Diagnostik und Behandlung der epiretinalen Gliose

Stand Oktober 2020

Auszug

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Neue Techniken zur Quantifizierung des Farbsinns bei Störungen der Zapfenfunktion

Experimentelle Therapieansätze für die Behandlung retinaler Dystrophien bei neuronalen Ceroid-Lipofuszinosen

Ein 27-jähriger Mann mit „Hornhauttrübung“ nach Astverletzung

Präoperatives Management bei subkonjunktivalen/subtenonalen glaukomchirurgischen Operationen unter besonderer Berücksichtigung des Gelimplantats (XEN®)

Ophthalmologische Manifestationen bei neuronalen Ceroid-Lipofuszinosen (NCL)

Einfluss der CNV-Gefäßmorphologie bei exsudativer altersabhängiger Makuladegeneration auf die Visusentwicklung und den Anti-VEGF-Therapiebedarf nach 1 Jahr

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde